 CAMBRIDGE, Mass.--BUSINESS WIRE--InVivo Therapeutics Holdings Corp. Nasdaq: NVIV, a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, which runs from March 17 March 19 from 9:00 am 5:00 pm ET. Dr. Tosellis presentation will provi 